Ophthalmic screening patterns among youths with diabetes enrolled in a large US managed care network

JAMA Ophthalmology

Volumn 135, Issue 5, 2017, Pages 432-438

  Wang, Sophia Y ^a   Andrews, Chris A ^a,b   Gardner, Thomas W ^b   Wood, Michael ^b   Singer, Kanakadurga ^b   Stein, Joshua D ^b,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; METFORMIN; SULFONYLUREA DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; BLACK PERSON; CHILD; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIAGNOSTIC TEST ACCURACY STUDY; EYE EXAMINATION; FEMALE; HAZARD RATIO; HISPANIC; HOUSEHOLD INCOME; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; JUVENILE; KAPLAN MEIER METHOD; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPHTHALMOLOGIST; OPTOMETRIST; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SOCIAL ASPECT; UNITED STATES; YOUNG ADULT; CLINICAL TRIAL; COMPLICATION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HEALTH INSURANCE; INCIDENCE; MULTICENTER STUDY; PATIENT COMPLIANCE; PROCEDURES; PROTOCOL COMPLIANCE; VISION TEST;

ADOLESCENT; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; GUIDELINE ADHERENCE; HUMANS; INCIDENCE; MALE; MANAGED CARE PROGRAMS; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; UNITED STATES; VISION SCREENING; YOUNG ADULT;

EID: 85025102530     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2017.0089     Document Type: Article

References (40)

1. Green A, Patterson CC; EURODIAB TIGER Study Group. Trends in the incidence of childhood-onset diabetes in Europe 1989-1998. Diabetologia. 2001; 44(3)(suppl 3):B3-B8.
2. Lin W-H, Wang M-C, Wang W-M, et al. Incidence of and mortality from type I diabetes in Taiwan from 1999 through 2010: a nationwide cohort study. PLoS One. 2014;9(1):e86172.
3. Day C. The rising tide of type 2 diabetes. Br J Diabetes Vasc Dis. 2001;1(1):37-43.
4. Dabelea D, Mayer-Davis EJ, Saydah S, et al; SEARCH for Diabetes in Youth Study. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA. 2014;311 (17):1778-1786.
5. Lipman TH, Levitt Katz LE, Ratcliffe SJ, et al. Increasing incidence of type 1 diabetes in youth: twenty years of the Philadelphia Pediatric Diabetes Registry. Diabetes Care. 2013;36(6):1597-1603.
6. Pinhas-Hamiel O, Zeitler P. The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr. 2005;146(5):693-700.
7. D’Adamo E, Caprio S. Type 2 diabetes in youth: epidemiology and pathophysiology. Diabetes Care. 2011;34(suppl 2):S161-S165.
8. Imperatore G, Boyle JP, Thompson TJ, et al; SEARCH for Diabetes in Youth Study Group. Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth. Diabetes Care. 2012;35(12): 2515-2520.
9. Broe R. Early risk stratification in pediatric type 1 diabetes. Acta Ophthalmol. 2015;93 Thesis 1(1):1-19.
10. Porta M, Allione A. Diabetic retinopathy and its relevance to paediatric age. An update. Pediatr Endocrinol Rev. 2004;1(4):404-411.
11. Thomas RL, Dunstan FD, Luzio SD, et al. Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service. Br J Ophthalmol. 2015;99(1):64-68.
12. Lian JX, Gangwani RA, McGhee SM, Chan CK, Lam CL, Wong DS; Primary Health Care Group. Systematic screening for diabetic retinopathy (DR) in Hong Kong: prevalence of DR and visual impairment among diabetic population. Br J Ophthalmol. 2016;100(2):151-155.
13. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med. 1993;328(23): 1676-1685.
14. AAO PPP Retina/Vitreous Panel, Hoskins Center for Quality Eye Care. Diabetic Retinopathy PPP - Updated 2016. American Academy of Ophthalmology. https://www.aao.org/preferred-practice-pattern/diabetic-retinopathy-ppp-updated-2016. Published February 24, 2016. Accessed December 12, 2016.
15. American Diabetes Association. Diabetic retinopathy. Diabetes Care. 2002;25(suppl 1): s90-s93.
16. Lueder GT, Silverstein J; American Academy of Pediatrics Section on Ophthalmology and Section on Endocrinology. Screening for retinopathy in the pediatric patient with type 1 diabetes mellitus. Pediatrics. 2005;116(1):270-273.
17. American Diabetes Association. Standards of medical care in diabetes–2010. Diabetes Care. 2010;33(suppl 1):S11-S61.
18. American Academy of Ophthalmology. Diabetic Retinopathy PPP—2014. https://www.aao.org/clinical-education. Accessed August 22, 2016.
19. Rosenberg JB, Friedman IB, Gurland JE. Compliance with screening guidelines for diabetic retinopathy in a large academic children’s hospital in the Bronx. J Diabetes Complications. 2011;25(4): 222-226.
20. Valent D, Pestak K, Otis M, Shubrook J. Type 2 diabetes in the pediatric population: are we meeting ADA clinical guidelines in Ohio? Clin Pediatr (Phila). 2010;49(4):316-322.
21. Schoenfeld ER, Greene JM, Wu SY, Leske MC. Patterns of adherence to diabetes vision care guidelines: baseline findings from the Diabetic Retinopathy Awareness Program. Ophthalmology. 2001;108(3):563-571.
22. Dorsey RR, Songer TJ, Zgibor JC, Orchard TJ. Influences on screening for chronic diabetes complications in type 1 diabetes. Dis Manag. 2006; 9(2):93-101.
23. International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). http://www.cdc.gov/nchs/icd/icd9cm.htm. Updated June 18, 2013. Accessed February 14, 2017.
24. Schneider EW, Mruthyunjaya P, Talwar N, Harris Nwanyanwu K, Nan B, Stein JD. Reduced fluorescein angiography and fundus photography use in the management of neovascular macular degeneration and macular edema during the past decade. Invest Ophthalmol Vis Sci. 2014;55(1): 542-549.
25. Wubben TJ, Talwar N, Blachley TS, et al. Rates of Vitrectomy among Enrollees in a United States Managed Care Network, 2001-2012. Ophthalmology. 2016;123(3):590-598.
26. Vanderbeek BL, Zacks DN, Talwar N, Nan B, Musch DC, Stein JD. Racial differences in age-related macular degeneration rates in the United States: a longitudinal analysis of a managed care network. Am J Ophthalmol. 2011;152(2): 273-282.e3.
27. Vanderloo SE, Johnson JA, Reimer K, et al. Validation of classification algorithms for childhood diabetes identified from administrative data. Pediatr Diabetes. 2012;13(3):229-234.
28. Brown M, Kuhlman D, Larson L, et al. Does availability of expanded point-of-care services improve outcomes for rural diabetic patients? Prim Care Diabetes. 2013;7(2):129-134.
29. Sloan FA, Bethel MA, Lee PP, Brown DS, Feinglos MN. Adherence to guidelines and its effects on hospitalizations with complications of type 2 diabetes. Rev Diabet Stud. 2004;1(1):29-38.
30. Nakhla M, Daneman D, To T, Paradis G, Guttmann A. Transition to adult care for youths with diabetes mellitus: findings from a Universal Health Care System. Pediatrics. 2009;124(6): e1134-e1141.
31. Puent BD, Nichols KK. Patients’ perspectives on noncompliance with diabetic retinopathy standard of care guidelines. Optometry. 2004;75(11):709-716.
32. Hartnett ME, Key IJ, Loyacano NM, Horswell RL, Desalvo KB. Perceived barriers to diabetic eye care: qualitative study of patients and physicians. Arch Ophthalmol. 2005;123(3):387-391.
33. Muñoz B, O’Leary M, Fonseca-Becker F, et al. Knowledge of diabetic eye disease and vision care guidelines among Hispanic individuals in Baltimore with and without diabetes. Arch Ophthalmol. 2008; 126(7):968-974.
34. Delorme C, Boisjoly HM, Baillargeon L, Turcotte P, Bernard PM. Screening for diabetic retinopathy: do family physicians know the Canadian guidelines? Can Fam Physician. 1998;44:1473-1479.
35. Wiggins MN, Landes RD, Bhaleeya SD, Uwaydat SH. Primary care physicians’ knowledge of the ophthalmic effects of diabetes. Can J Ophthalmol. 2013;48(4):265-268.
36. Kirkman MS, Williams SR, Caffrey HH, Marrero DG. Impact of a program to improve adherence to diabetes guidelines by primary care physicians. Diabetes Care. 2002;25(11):1946-1951.
37. Garg S, Jani PD, Kshirsagar AV, King B, Chaum E. Telemedicine and retinal imaging for improving diabetic retinopathy evaluation. Arch Intern Med. 2012;172(21):1677-1678.
38. Kolomeyer AM, Nayak NV, Simon MA, et al. Feasibility of retinal screening in a pediatric population with type 1 diabetes mellitus. J Pediatr Ophthalmol Strabismus. 2014;51(5):299-306.
39. Tapley JL, McGwin G Jr, Ashraf AP, et al. Feasibility and efficacy of diabetic retinopathy screening among youth with diabetes in a pediatric endocrinology clinic: a cross-sectional study. Diabetol Metab Syndr. 2015;7:56.
40. Patty L, Wu C, Torres M, Azen S, Varma R; Los Angeles Latino Eye Study Group. Validity of self-reported eye disease and treatment in a population-based study: the Los Angeles Latino Eye Study. Ophthalmology. 2012;119(9):1725-1730.